Professor Brian MacCraith:

That is a real and interesting question and it is already out there. The Deputy may have seen the announcement earlier this week that Sanofi has agreed to take on the manufacture of extra vaccine supplies for Pfizer. This is highly unusual in a highly competitive industry. In anticipation of this question, I have spoken with IDA Ireland, which is in regular contact with all the pharmaceutical companies here. Ireland has benefited from the fact that some of the pharmaceutical companies have shifted the manufacture of other elements to plants here to make way for a focus on the vaccine in other locations. The key issue is that IDA Ireland is in direct and regular contact with all the relevant pharma companies in relation to the totality of their global supply chains, and to see if an opportunity exists. That dialogue is ongoing but there is nothing to report in actual developments on that matter at this time.